Both dupilumab and mepolizumab were originally approved for asthma but were subsequently studied in patients with COPD who continue to experience symptoms and moderate-to-severe exacerbations despite ...

Breathing in microplastics can cause inflammation and damage to the lungs, potentially increasing the risk of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), ...

New Global Burden of Disease data show sustained mortality declines; however, noncommunicable diseases, climate exposure, and ...

A study has found that even non-smokers who have suffered from chronic lung disease or have a family history of the condition ...

November is National Chronic Obstructive Pulmonary Disease Awareness Month. It’s time to raise awareness about lung disease within our communities. By understanding the causes, reducing our risk ...

Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterised by persistent airflow limitation and chronic inflammation. Beyond its primary pulmonary manifestations, ...

Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...

Inhaled maintenance therapy is underused among hospitalized patients with COPD in China, even in those with frequent prior hospitalizations.

Texas Health Presbyterian Hospital Kaufman is strengthening community wellness through its Healthy Education Lifestyles ...

Rheumatoid arthritis (RA) patients face increased risk for interstitial lung disease (ILD) that is worsened further by the ...